Record overview
Status and phase
Status: TERMINATED
Phase: PHASE1, PHASE2
Sponsor: National Cancer Institute (NCI)
Condition: Breast Cancer, Brain Metastasis, Brain Cancer
NCT03190967
T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
The phase II portion was never started as we could no longer get the drug from the manufacturer.